Amyloidogenic Transthyretin (ATTR) Amyloidosis
3 clinical trials · Condition
◉ Watch Amyloidogenic Transthyretin (ATTR) Amyloidosis
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) (NCT07116473) | Eidos Therapeutics, a BridgeBio company | 2026-11-01 |
| PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels (NCT07538518) | Lorena Saelices | 2026-06-01 |
| A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis (NCT03336580) | Prothena Biosciences Limited | 2018-04-05 |
Track Amyloidogenic Transthyretin (ATTR) Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.